(NASDAQ: AVR) Anteris Technologies Global's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 66.89%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 60.9%.
Anteris Technologies Global's earnings in 2025 is N/A.On average, 2 Wall Street analysts forecast AVR's earnings for 2025 to be -$68,105,951, with the lowest AVR earnings forecast at -$72,957,826, and the highest AVR earnings forecast at -$63,254,076.
In 2026, AVR is forecast to generate -$54,269,122 in earnings, with the lowest earnings forecast at -$54,269,122 and the highest earnings forecast at -$54,269,122.